Specifically, cPBA-BE could reverse the content of hepatitis biomarkers such as serum AST, ALT, LDH and ammonia, and relieve the symptoms of edema, hemorrhage, and cell necrosis in liver tissues. This evidence concerns the gene GPT and hepatitis A virus infection.